Annual Cash & Cash Equivalents:
$196.81M+$167.65M(+574.98%)Summary
- As of today, MAZE annual cash & cash equivalents is $196.81 million, with the most recent change of +$167.65 million (+574.98%) on December 31, 2024.
- During the last 3 years, MAZE annual cash & cash equivalents has risen by +$96.89 million (+96.97%).
- MAZE annual cash & cash equivalents is now at all-time high.
Performance
MAZE Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$264.54M-$29.83M(-10.13%)Summary
- As of today, MAZE quarterly cash & cash equivalents is $264.54 million, with the most recent change of -$29.83 million (-10.13%) on June 30, 2025.
- Over the past year, MAZE quarterly cash & cash equivalents has increased by +$89.48 million (+51.11%).
- MAZE quarterly cash & cash equivalents is now -10.13% below its all-time high of $294.37 million, reached on March 31, 2025.
Performance
MAZE Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MAZE Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +575.0% | +51.1% |
| 3Y3 Years | +97.0% | - |
| 5Y5 Years | +97.0% | - |
MAZE Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +575.0% | -10.1% | +807.3% |
| 5Y | 5-Year | at high | +575.0% | -10.1% | +807.3% |
| All-Time | All-Time | at high | +575.0% | -10.1% | +807.3% |
MAZE Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $264.54M(-10.1%) |
| Mar 2025 | - | $294.37M(+49.6%) |
| Dec 2024 | $196.81M | $196.81M(+31.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $149.61M(-14.5%) |
| Jun 2024 | - | $175.06M(+500.4%) |
| Dec 2023 | $29.16M(-70.8%) | $29.16M |
| Dec 2022 | $99.92M | - |
FAQ
- What is Maze Therapeutics, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Maze Therapeutics, Inc.?
- What is Maze Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Maze Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Maze Therapeutics, Inc.?
- What is Maze Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Maze Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of MAZE is $196.81M
What is the all-time high annual cash & cash equivalents for Maze Therapeutics, Inc.?
Maze Therapeutics, Inc. all-time high annual cash & cash equivalents is $196.81M
What is Maze Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, MAZE annual cash & cash equivalents has changed by +$167.65M (+574.98%)
What is Maze Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of MAZE is $264.54M
What is the all-time high quarterly cash & cash equivalents for Maze Therapeutics, Inc.?
Maze Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $294.37M
What is Maze Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, MAZE quarterly cash & cash equivalents has changed by +$89.48M (+51.11%)